 0 Table of Contents |
  1 Home |
  2 Changes |
  3 Combo Therapies |
  4 Copay Eligibility Questions |
  5 Copay Mapping |
  6 Copay Value Sets |
  7 Enrollment |
  8 Enrollment Mapping |
  9 Error Handling |
  10 History |
  11 Message Structure |
  12 Message Submission |
  13 Onboarding |
  14 Products Specifics |
  15 Questionnaire |
  16 Regimen Products |
  17 Release 2024 August 5 |
  18 Release 2024 Dec 13 |
  19 Release 2024 July |
  20 Release 2024 June 14 |
  21 Release 2024 June 28 |
  22 Release 2024 May 17 |
  23 Release 2024 May 3 |
  24 Release 2024 May 31 |
  25 Release 2024 Nov 15 |
  26 Release 2024 Nov 29 |
  27 Release 2024 Oct 11 |
  28 Release 2024 Oct 18 |
  29 Release 2024 Oct 29 |
  30 Release 2024 Oct 4 |
  31 Release 2024 Sept 25 |
  32 Release 2025 Apr |
  33 Release 2025 Feb 14 |
  34 Release 2025 Feb 28 |
  35 Release 2025 Jan 31 |
  36 Release 2025 Jul 03 |
  37 Release 2025 Oct |
  38 Release 2026 Feb 06 |
  39 Release 2026 MAR |
  40 Release Q 42025 |
  41 Search Conventions |
  42 Services |
  43 Status Update Mapping |
  44 Systematic Queries |
  45 Technical Hints |
  46 Testing |
  47 Updates |
  48 Use Cases |
  49 Validation Rules |
  50 Artifacts Summary |
   50.1 UAPI CapabilityStatement - Genentech FHIR Server |
   50.2 ServiceRequestTypeSearch |
   50.3 External - Alecensa Questionnaire |
   50.4 External - Cotellic Copay Questionnaire |
   50.5 External - Cotellic Questionnaire |
   50.6 External - Herceptin Questionnaire |
   50.7 External - Lucentis Questionnaire |
   50.8 UAPI Bundle - AS Enrollment |
   50.9 UAPI Bundle - Copay Enrollment |
   50.10 UAPI Bundle - Copay Error Reconciliation |
   50.11 UAPI Bundle - Copay Management |
   50.12 UAPI Bundle - Copay Request-Response |
   50.13 UAPI Bundle - Patient Consent Form Only Enrollment |
   50.14 UAPI Bundle - Query Message |
   50.15 UAPI Bundle - Query Response Message |
   50.16 UAPI Bundle - Query Response Multi Patient Message |
   50.17 UAPI Bundle - Search Result |
   50.18 UAPI Bundle - Search Result Patient |
   50.19 UAPI Bundle - Status Update |
   50.20 UAPI Condition |
   50.21 UAPI Consent |
   50.22 UAPI Coverage |
   50.23 UAPI CoverageEligibilityRequest |
   50.24 UAPI CoverageEligibilityResponse |
   50.25 UAPI MedicationRequest |
   50.26 UAPI MessageHeader |
   50.27 UAPI Organization |
   50.28 UAPI Patient |
   50.29 UAPI Practitioner |
   50.30 UAPI Provenance |
   50.31 UAPI RelatedPerson |
   50.32 UAPI ServiceRequest |
   50.33 Exact ContactPoint Extension |
   50.34 UAPI # of Appeals Allowed |
   50.35 UAPI Additional Documents Required |
   50.36 UAPI Appeal Submission Deadline |
   50.37 UAPI BI - Benefits Summary |
   50.38 UAPI BI - Billing Instructions |
   50.39 UAPI BI - Specialty Pharmacy |
   50.40 UAPI Coverage - Card issuance date |
   50.41 UAPI Coverage Plan Year |
   50.42 UAPI Coverage Reference Number |
   50.43 UAPI CoverageEligibilityRequest Product |
   50.44 UAPI CoverageEligibilityRequest ServiceRequestType |
   50.45 UAPI CoverageEligibilityResponse Shipment Method |
   50.46 UAPI CoverageEligibilityResponse Status |
   50.47 UAPI Estimated Appeal TAT |
   50.48 UAPI MedicationRequest Dispense Quantity Detailed Breakdown |
   50.49 UAPI MedicationRequest Dispenser Instructions |
   50.50 UAPI MessageHeader Timestamp |
   50.51 UAPI PCP Referral Effective Date |
   50.52 UAPI PCP Referral On-file? |
   50.53 UAPI PCP Referral Recertification Date |
   50.54 UAPI PCP Referral Required? |
   50.55 UAPI Peer to Peer Available |
   50.56 UAPI Practitioner Preferred Contact Method |
   50.57 UAPI Practitioner Shipment Method |
   50.58 UAPI PreD Est. TAT |
   50.59 UAPI Prior Auth Est. TAT |
   50.60 UAPI Spend Down Frequency |
   50.61 UAPI Value Set - Benefit Type |
   50.62 UAPI Value Set - Copay Adjudication Categories |
   50.63 UAPI Value Set - Copay Insurance Plan Types |
   50.64 UAPI Value Set - Coverage Outcome |
   50.65 UAPI Value Set - Insurance Unit |
   50.66 UAPI Value Set - Organization Type |
   50.67 UAPI Value Set - PreDetermination |
   50.68 UAPI Value Set - Prescriber Contact Method |
   50.69 UAPI Value Set - Prescriber Contact Time |
   50.70 UAPI Value Set - Product Authorization |
   50.71 UAPI Value Set - Product JCode |
   50.72 UAPI Value Set - Product Name |
   50.73 UAPI Value Set - Product Service |
   50.74 UAPI Value Set - Regimen Product Name |
   50.75 UAPI Value Set - Service Request Type |
   50.76 UAPI Value Set - Shipment Method |
   50.77 UAPI Value Set - Specialty Pharmacy |
   50.78 UAPI Value Set - System Event Type |
   50.79 UAPI Code System - Authorization-Supporting Documents Submission |
   50.80 UAPI Code System - Benefit Type |
   50.81 UAPI Code System - Copay Adjudication Category |
   50.82 UAPI Code System - Copay assigned card type |
   50.83 UAPI Code System - Copay Benefit Types |
   50.84 UAPI Code System - Copay Brand ID |
   50.85 UAPI Code System - Copay Claim Status |
   50.86 UAPI Code System - Copay Claim Supporting Information Category |
   50.87 UAPI Code System - Copay CRX enrollment channel |
   50.88 UAPI Code System - Copay CRX enrollment status |
   50.89 UAPI Code System - Copay CRX workflow selection |
   50.90 UAPI Code System - Copay Enrollment Errors |
   50.91 UAPI Code System - Copay Genentech processing error |
   50.92 UAPI Code System - Copay Insurance Plan Types |
   50.93 UAPI Code System - Copay Payment Type |
   50.94 UAPI Code System - Copay Task input types |
   50.95 UAPI Code System - Copay Task output types |
   50.96 UAPI Code System - Copay Who is applying |
   50.97 UAPI Code System - CoverageEligibilityRequest outcome |
   50.98 UAPI Code System - Event Type |
   50.99 UAPI Code System - Insurance Unit |
   50.100 UAPI Code System - PreDetermination |
   50.101 UAPI Code System - Prescriber Contact Methods |
   50.102 UAPI Code System - Prescriber Contact Times |
   50.103 UAPI Code System - Product JCode |
   50.104 UAPI Code System - Product Names |
   50.105 UAPI Code System - Product/Service |
   50.106 UAPI Code System - Regimen Product Names |
   50.107 UAPI Code System - Service Request Type |
   50.108 UAPI Code System - Shipment Methods |
   50.109 UAPI Code System - Specialty Pharmacy |
   50.110 as-venclexta-mr |
   50.111 External - Alecensa QuestionnaireResponse |
   50.112 External - Herceptin Hylecta QuestionnaireResponse |
   50.113 External - Medication Request: Actemra Intravenous |
   50.114 External - Medication Request: Actemra Subcutaneous |
   50.115 External - Medication Request: Enspryng |
   50.116 External - Medication Request: Evrysdi |
   50.117 External - Medication Request: Hemlibra |
   50.118 External - Medication Request: Itovebi |
   50.119 External - Medication Request: Ocrevus |
   50.120 External - Medication Request: Ocrevus Zunovo - GPF |
   50.121 External - Medication Request: Ocrevus Zunovo - Starter |
   50.122 External - Medication Request: Pulmozyme |
   50.123 External - Medication Request: Rituxan for Immunology |
   50.124 External - Medication Request: Tecentriq Hybreza |
   50.125 External - MedicationRequest: Alecensa |
   50.126 External - MedicationRequest: Cotellic |
   50.127 External - MedicationRequest: Erivedge |
   50.128 External - MedicationRequest: Herceptin |
   50.129 External - MedicationRequest: Lucentis |
   50.130 External - MedicationRequest: Lunsumio |
   50.131 External - MedicationRequest: Rozlytrek |
   50.132 External - MedicationRequest: Vabysmo |
   50.133 External - Resource Example: OperationOutcome |
   50.134 External - Resource Example: Organization (Practice) |
   50.135 External - Resource Example: MessageHeader |
   50.136 External - Rozlytrek QuestionnaireResponse |
   50.137 External - SOT Organization example |
   50.138 External - UAPI AS Digital Consent: Consent by RelatedPerson |
   50.139 External - UAPI AS Enrollment: Actemra Subcutaneous |
   50.140 External - UAPI AS Enrollment: Alecensa |
   50.141 External - UAPI AS Enrollment: Avastin |
   50.142 External - UAPI AS Enrollment: Columvi |
   50.143 External - UAPI AS Enrollment: Cotellic |
   50.144 External - UAPI AS Enrollment: Enspryng |
   50.145 External - UAPI AS Enrollment: Erivedge |
   50.146 External - UAPI AS Enrollment: Gazyva |
   50.147 External - UAPI AS Enrollment: Hemlibra |
   50.148 External - UAPI AS Enrollment: Herceptin Hylecta |
   50.149 External - UAPI AS Enrollment: Lucentis |
   50.150 External - UAPI AS Enrollment: Ocrevus |
   50.151 External - UAPI AS Enrollment: Perjeta |
   50.152 External - UAPI AS Enrollment: Polivy |
   50.153 External - UAPI AS Enrollment: Pulmozyme |
   50.154 External - UAPI AS Enrollment: Rituxan for Immunology |
   50.155 External - UAPI AS Enrollment: Rituxan for Oncology |
   50.156 External - UAPI AS Enrollment: Rituxan Hycela |
   50.157 External - UAPI AS Enrollment: Rozlytrek |
   50.158 External - UAPI AS Enrollment: Susvimo |
   50.159 External - UAPI AS Enrollment: Vabysmo |
   50.160 External - UAPI AS Enrollment: Venclexta |
   50.161 External - UAPI AS Enrollment: Xolair |
   50.162 External - UAPI AS Enrollment: Evrysdi |
   50.163 External - UAPI AS Enrollment: Kadcyla |
   50.164 External - UAPI AS Enrollment: Phesgo |
   50.165 External - UAPI AS Enrollment: Tecentriq |
   50.166 External - UAPI AS Patient Consent Only |
   50.167 External - UAPI AS Patient Consent: Consent for Marketing Info |
   50.168 External - UAPI Copay Card Enrollment REQUEST 1 |
   50.169 External - UAPI Copay Card Enrollment REQUEST 2 |
   50.170 External - UAPI Copay Card Enrollment REQUEST 3 |
   50.171 External - UAPI Copay Card Enrollment REQUEST 4 |
   50.172 External - UAPI Copay Card Enrollment REQUEST 5 |
   50.173 External - UAPI Copay Card Enrollment REQUEST 6 |
   50.174 External - UAPI Copay Card Enrollment RESPONSE 1 |
   50.175 External - UAPI Copay Card Enrollment RESPONSE 2 |
   50.176 External - UAPI Copay Card Enrollment RESPONSE 3 |
   50.177 External - UAPI Copay claim upsert - bundle of claim bundles |
   50.178 External - UAPI Copay Explanation of Benefit in copay enrollment response |
   50.179 External - UAPI Copay Explanation of Benefit in copay enrollment response |
   50.180 External - UAPI Copay Operation Outcome in copay enrollment response with errors |
   50.181 External - UAPI Copay request-response enrollment bundle - success |
   50.182 External - UAPI Copay Search Request |
   50.183 External - UAPI Copay Update Request |
   50.184 External - UAPI Copay Update Response |
   50.185 External - UAPI GPF Enrollment: Herceptin |
   50.186 External - UAPI GPF Enrollment: Lunsumio |
   50.187 External - UAPI GPF Enrollment: Itovebi |
   50.188 External - UAPI GPF Enrollment: Susvimo |
   50.189 External - UAPI Response to Copay Search request - example returning 2 matching patients. |
   50.190 External - UAPI Status Query REQUEST |
   50.191 External - UAPI Status Query RESPONSE: BIPA |
   50.192 External - UAPI Status Query RESPONSE: GPF |
   50.193 Internal - UAPI AS Enrollment for MPS Redesign biPA Bundle Before (Ocrevus) |
   50.194 Internal - UAPI Copay request-response combined bundle - error |
   50.195 Internal - UAPI Copay request-response combined bundle - success |
   50.196 Internal - UAPI Query 2 |
   50.197 Internal - UAPI Status Update C&R |
   50.198 Internal - UAPI Status Update GPF |
   50.199 mr-Avastin |
   50.200 mr-Columvi |
   50.201 mr-Gazyva |
   50.202 mr-HerceptinHylecta |
   50.203 mr-Kadcyla |
   50.204 mr-Perjeta |
   50.205 mr-Perjeta1 |
   50.206 mr-Phesgo |
   50.207 mr-Phesgo1 |
   50.208 mr-Polivy |
   50.209 mr-Polivy1 |
   50.210 mr-Pulmozyme |
   50.211 mr-Regimen |
   50.212 mr-Regimen2 |
   50.213 mr-RituxanForOncology |
   50.214 mr-RituxanHycela |
   50.215 mr-RituxanHycela1 |
   50.216 mr-RituxanOncology |
   50.217 mr-Tecentriq2 |
   50.218 mr-Tecentriq3 |
   50.219 mr-xolair |
   50.220 mr-Zelboraf |
   50.221 mr-Zelboraf1 |